ArticleBiotechnology letters2018

Knockout of CTNNB1 by CRISPR-Cas9 technology inhibits cell proliferation through the Wnt/β-catenin signaling pathway.

Lihong Guan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.